Evaluation of Clinical Outcomes of Unruptured bAVMs Treated With Medical Management Alone Based on Multimodal CT

Sponsor
Beijing Tiantan Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05449106
Collaborator
Beijing Hospital (Other), The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Other), The First Affiliated Hospital of Zhengzhou University (Other)
200
4
120
50
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the role of multimodal CT in evaluating and predicting different clinical outcomes in patients with unruptured brain arteriovenous malformations with medical management alone.

This study will be undertaken in the following aspects:
  1. Morphological, structural and imaging histological signal analysis based on multimodal CT to explore the relationship between imaging features and different clinical outcomes of bAVMs.

  2. Hemodynamic and flow pattern analysis of local and peripheral bAVMs based on multimodal CT to explore the association between blood flow features and different clinical outcomes.

  3. Based on multimodal CT and deep learning algorithms to create an automated segmentation model for bAVMs and a prediction model for distinct clinical outcomes.

The obtained patient information includes: Baseline information, CT, MRI, DSA (Optional), and follow-up information. Follow-up will be undertaken at 6 months, 12 months, 24 months and 36 months after enrollment with the following primary observation.

Main observation endpoints:
  1. Hemorrhage events associated with bAVMs

  2. New epilepsy symptoms or exacerbations

  3. New neurological dysfunction(including motor dysfunction, cognitive dysfunction, etc).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This study is a Long-term, multi-center, prospective registry study, and was supported by China National Key Research and Development Program Project No. 2021YFC2500502.

    The purpose of this study is to investigate the role of multimodal Computer Tomography(CT) in evaluating and predicting different clinical outcomes in patients with unruptured brain arteriovenous malformations with medical management alone.

    This study will be undertaken in the following aspects:
    1. Morphological, structural and imaging histological signal analysis based on multimodal CT to study the relationship between imaging features and different clinical outcomes of bAVMs.

    2. Hemodynamic and flow pattern analysis of local and peripheral bAVMs based on multimodal CT to explore the association between blood flow features and different clinical outcomes.

    3. Based on multimodal CT and deep learning algorithms to create an automated segmentation model for bAVMs and a prediction model for distinct clinical outcomes.

    4. To compare the efficacy of multimodal CT and MRI in evaluating the clinical outcomes of unruptured cerebral arteriovenous malformations.

    The obtained patient information includes:
    1. Baseline information

    2. CT images: including non-contrast CT(NCCT), CT Angiography, CT perfusion

    3. Magnetic Resonance Imaging(MRI): including T1-weighted image, T2-weighted image, T2-FLAIR, Time of Flight MR angiography(TOF-MRA), diffusion-weighted imaging(DWI), susceptibility weighted imaging(SWI)

    4. Digital subtraction angiography(DSA, optional)

    5. Follow-up information: follow-up will be undertaken at 6 months, 12 months, 24 months and 36 months after enrollment with the following primary observation.

    Main observation endpoints:
    1. Hemorrhage events associated with bAVMs, ensuring by CT scan;

    2. New epilepsy symptoms or exacerbations, ensuring by consultation or EEG ;

    3. New neurological dysfunction(including motor dysfunction, cognitive dysfunction, etc), ensuring by consultation, physical examination or any radiology examination.

    Inclusion criteria

    1. Patients with confirmed diagnosis of bAVMs in the cerebrum, basal ganglia, thalamus, corpus callosum, cerebellum and brainstem;

    2. Patients with no history of previous bAVM related hemorrhage confirmed by CT examination, or have radiographic examination completed prior to the hemorrhage.

    3. Patients with radiographic examinations before any treatment;

    Exclusion criteria.

    1. Patients with simple arteriovenous fistula;

    2. Patients with combined dural arteriovenous fistula;

    3. Arteriovenous malformations occurring in the spinal cord;

    4. Pregnant patients were not included in this study.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Clinical Outcomes of Unruptured Brain Arteriovenous Malformations Treated With Medical Management Alone Based on Multimodal Computer Tomography: A Long-term Multicenter Prospective Cohort Study
    Actual Study Start Date :
    May 25, 2022
    Anticipated Primary Completion Date :
    May 25, 2027
    Anticipated Study Completion Date :
    May 25, 2032

    Outcome Measures

    Primary Outcome Measures

    1. Number of participants with rupture events [3 years after enrollment]

      Arteriovenous malformation rupture during follow-up before treatment

    2. Number of participants with epilepsy Progression [3 years after enrollment]

      Progression of seizure symptoms during follow-up, including but not limited to more frequent seizures, worsening of symptoms, etc.

    3. Number of participants with new onset neurological dysfunction [3 years after enrollment]

      New neurological deficits during the follow-up period, including motor deficits, cognitive deficits, etc.

    Secondary Outcome Measures

    1. Number of participants receiving treatment [3 years after enrollment]

      Patients receiving any form of intervention during the follow-up period will stop the follow-up

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients with confirmed diagnosis of brain arteriovenous malformations in the brain, basal ganglia, thalamus, corpus callosum, cerebellum and other locations.

    2. Patients with no history of previous arteriovenous malformation-related hemorrhage and no arteriovenous malformation-related hemorrhage confirmed by CT examination.

    3. Patients with Radiographic examinations completed without any treatment

    Exclusion Criteria:
    1. Patients with simple arteriovenous fistula.

    2. Patients with combined dural arteriovenous fistulas.

    3. Arteriovenous malformations occurring in the spinal cord.

    4. Pregnant patients were not included in this study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beijing Tiantan Hospital, Capital Medical University Beijing Beijing China 100070
    2 Beijing Hospital Beijing Beijing China 102249
    3 The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China 450052
    4 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Nanjing Jiangsu China 210008

    Sponsors and Collaborators

    • Beijing Tiantan Hospital
    • Beijing Hospital
    • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    • The First Affiliated Hospital of Zhengzhou University

    Investigators

    • Study Chair: Dong Zhang, Doctor, Beijing Tiantan Hospital, Beijing Hospital
    • Study Director: Shaosen Zhang, Doctor, Beijing Tiantan Hospital
    • Principal Investigator: Guosheng Zhou, The First Affiliated Hospital of Zhengzhou University
    • Principal Investigator: Yongbo Yang, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Beijing Tiantan Hospital
    ClinicalTrials.gov Identifier:
    NCT05449106
    Other Study ID Numbers:
    • KY2022-054-02
    First Posted:
    Jul 8, 2022
    Last Update Posted:
    Jul 18, 2022
    Last Verified:
    Jul 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Beijing Tiantan Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 18, 2022